Search Beyond News…

Brink's avoids intensive UK antitrust probe by proposing divestiture of NoteMachine/TestLink UK

Executive summary: Brink's has received in-principle approval from the CMA for a remedy involving the sale of its NoteMachine/TestLink UK businesses to secure its acquisition of NCR Atleos. The divestiture prevents a lengthy and costly Phase 2 antitrust investigation in the UK, smoothing the path for the consolidation of cash management services.

Who is involved: Brink's, NCR Atleos, and the UK Competition and Markets Authority (CMA).

Likely next (inference): Final regulatory sign-off on the divestiture terms and the formal completion of the NCR Atleos acquisition.

The UK Competition and Markets Authority’s in‑principle acceptance of Brink’s proposed remedy clears a significant procedural hurdle for the company’s planned acquisition of NCR Atleos. By offering to divest the NoteMachine and TestLink UK businesses, Brink’s aims to address the CMA’s concerns that the combined entity could lessen competition in the cash‑handling and ATM services markets. This concession avoids a potentially lengthy Phase 2 investigation, which would have delayed the transaction and introduced uncertainty for both parties and their customers. From a business perspective, the remedy signals that Brink’s is willing to restructure parts of its UK portfolio to secure regulatory approval, a tactic that can preserve deal momentum while appeasing antitrust watchdogs. Assuming the CMA’s final approval follows the same line, the acquisition is likely to proceed on a timeline closer to the parties’ original expectations, allowing Brink’s to integrate NCR Atleos’s technology and service offerings without the extended oversight that a Phase 2 referral would impose. The near‑term outlook therefore points toward a completed transaction and subsequent integration efforts, with the divested NoteMachine and TestLink UK assets expected to be transferred to a buyer that maintains competitive pressure in the UK cash‑management sector.

What's next — scenarios

Inference: scenarios and probabilities are Beyond's assessment, not reported fact.

Base: Successful divestiture and deal completion (75%)

Brink's successfully integrates NCR Atleos while offloading non-core or problematic UK assets.

Downside: Regulatory pushback on divestiture scope (20%)

The CMA demands additional assets be sold, increasing deal costs and complexity.

Upside: Faster integration due to rapid regulatory clearance (5%)

The deal closes ahead of schedule, allowing Brink's to realize synergies earlier.

What to watch

Timeline

Analysis — what this means

Likely next events

Sectors affected

Regulatory implications

Key entities

Sources

Related cases

Browse the full archive →